Clinical trial
SURPASS-5: evaluating tirzepatide as add-on to basal insulin
The background insulin regimen distinguishes this trial from monotherapy research.
Read the study note ↗THE RESEARCH LIBRARY
190 source-linked study notes. Explore the design, findings and limits behind the headline.
Clinical trial
The background insulin regimen distinguishes this trial from monotherapy research.
Read the study note ↗Clinical trial
A controlled trial tested a specific complication, rather than a broad immune-health claim.
Read the study note ↗Clinical trial
Early combination studies prioritize safety and exposure before definitive efficacy questions.
Read the study note ↗Clinical trial
A phase 2 study investigated weight change and tolerability for an amylin analogue.
Read the study note ↗Preclinical study
Rats received DSIP before and after experimental arterial occlusion, followed by motor testing and measurement of brain injury.
Read the study note ↗Clinical trial
The short study separated a clamp-based metabolic result from unchanged oxidative-stress measures.
Read the study note ↗Mixed evidence
Animal intervention experiments and measurements after human exercise answer different questions.
Read the study note ↗Preclinical study
A rat social-stress experiment measured circulating cytokines after repeated exposure; the title and methods describe Selank.
Read the study note ↗Clinical trial
A placebo-controlled obesity trial provides a starting point for reading the semaglutide evidence.
Read the study note ↗Preclinical study
A later rat study investigated protein markers connected with inflammation and cell survival.
Read the study note ↗Analytical study
Researchers screened drug-response scores against transcriptomic and clinical datasets from primary and recurrent glioma cohorts.
Read the study note ↗Clinical trial
The diabetes population makes this a different question from STEP 1.
Read the study note ↗